03 January 2019 : Laboratory Research
Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway
DOI: 10.12659/MSM.912929
Med Sci Monit 2019; 25:77-86
HTML version available soon